Carcinoma Clinical Trials
A listing of Carcinoma medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.
Found 6031 clinical trials
The Study of KN046 in Combination With Lenvatinib in Advanced Hepatocellular Carcinoma
Lenvatinib(TKI) for the treatment of advanced hepatocellular carcinoma.
- 0 views
- 24 May, 2022
- 1 location
TQB2450 Combined With Anlotinib Hydrochloride in the Perioperative Treatment of Hepatocellular Carcinoma Hydrochloride Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma With a High Risk of Recurrence or Metastasis
In this study, single cell transcriptome sequencing will be performed on the tissue samples punctured and the surgically resected specimens to explore the gene mutation sites related to efficacy
- 0 views
- 24 May, 2021
- 1 location
Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA
carcinoma patients monitored by ctDNA.
- 0 views
- 24 Mar, 2022
- 2 locations
Feasibility of Neo-adjuvant Versus Adjuvant Chemotherapy in Upper Tract Urothelial Carcinoma (URANUS)
The aim of this study is to explore feasibility of Upper Tract Urothelial Carcinoma (UTUC) treatments based in real world data in various European countries. The study will allow to gain insight
- 1 views
- 21 Apr, 2022
- 17 locations
Immune Checkpoint Inhibitor and MR-guided SBRT for Limited Progressive Metastatic Carcinoma.
This is an open label single arm phase 2 clinical trial in patients with metastatic solid malignancy of any histology who have previously experienced limited progression in at least 1 and up to 5 lesions while on immune checkpoint inhibitors monotherapy.
- 0 views
- 06 May, 2022
- 1 location
Donafenib and Toripalimab Combined With TACE in Patients With Unresectable Hepatocellular Carcinoma
Hepatocellular Carcinoma.
- 0 views
- 02 Apr, 2021
- 1 location
Camrelizumab Combined With Apatinib for Perioperative Treatment of Resectable Primary Hepatocellular Carcinoma
This is A prospective, one-arm, phase II clinical study of Camrelizumab combined with apatinib for perioperative treatment of resectable primary hepatocellular carcinoma with a high risk of
- 0 views
- 11 Nov, 2021
- 1 location
Efficacy and Safety of Neoadjuvant Surufatinib for Patients With Salivary Gland Carcinomas
The objective is to investigate the efficacy and safety of Surufatinib Neoadjuvant Therapy for Locally Advanced Primary Saliary Gland Adenocarcinoma.
- 0 views
- 28 Aug, 2021
- 1 location
B010-A Injection for Treating Patients With GPC3 Positive Advanced Hepatocellular Carcinoma
This is an Open-label, Single Arm study to observe the safety and tolerability of B010-A in the treatment of advanced hepatocellular carcinoma.
- 0 views
- 03 Jan, 2022
- 1 location
Induction Chemotherapy Followed by Radiotherapy Alone or Concurrent Chemoradiotherapy in Nasopharyngeal Carcinoma (IRCNPC)
nasopharyngeal carcinoma (NPC) patients with a satisfactory tumor response (complete response or partial response) after neoadjuvant chemotherapy (NACT).
- 0 views
- 25 Feb, 2022
- 1 location